129 related articles for article (PubMed ID: 30467187)
1. A small change makes a big difference in Hodgkin lymphoma.
Hutchings M
Blood; 2018 Nov; 132(21):2214-2215. PubMed ID: 30467187
[No Abstract] [Full Text] [Related]
2. New staging and response criteria for non-Hodgkin lymphoma and Hodgkin lymphoma.
Cheson BD
Radiol Clin North Am; 2008 Mar; 46(2):213-23, vii. PubMed ID: 18619377
[TBL] [Abstract][Full Text] [Related]
3. Value of positron emission tomography in diagnosing subcutaneous panniculitis-like T-cell lymphoma.
Bennani-Baiti B; Yadav S; Flynt L; Bennani-Baiti N
J Clin Oncol; 2015 Apr; 33(10):1216-7. PubMed ID: 25691676
[No Abstract] [Full Text] [Related]
4. Update on Hodgkin lymphoma from a radiologist's perspective.
Levine I; Kalisz K; Smith DA; Tirumani SH; Ramaiya NH; Alessandrino F
Clin Imaging; 2020 Sep; 65():65-77. PubMed ID: 32361412
[TBL] [Abstract][Full Text] [Related]
5. Utility of FDG-PET/CT in follow-up of children treated for Hodgkin and non-Hodgkin lymphoma.
Rhodes MM; Delbeke D; Whitlock JA; Martin W; Kuttesch JF; Frangoul HA; Shankar S
J Pediatr Hematol Oncol; 2006 May; 28(5):300-6. PubMed ID: 16772881
[TBL] [Abstract][Full Text] [Related]
6. Do not abandon the bone marrow biopsy yet in diffuse large B-cell lymphoma.
Adams HJ; Kwee TC
J Clin Oncol; 2015 Apr; 33(10):1217. PubMed ID: 25691675
[No Abstract] [Full Text] [Related]
7. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
8. Imaging for diagnosis, staging and response assessment of Hodgkin lymphoma and non-Hodgkin lymphoma.
McCarten KM; Nadel HR; Shulkin BL; Cho SY
Pediatr Radiol; 2019 Oct; 49(11):1545-1564. PubMed ID: 31620854
[TBL] [Abstract][Full Text] [Related]
9. Interim PET-CT Scan in Advanced Hodgkin's Lymphoma.
Adams HJ; Kwee TC
N Engl J Med; 2016 Sep; 375(10):999. PubMed ID: 27602677
[No Abstract] [Full Text] [Related]
10. Imaging for Staging and Response Assessment in Lymphoma.
Johnson SA; Kumar A; Matasar MJ; Schöder H; Rademaker J
Radiology; 2015 Aug; 276(2):323-38. PubMed ID: 26203705
[TBL] [Abstract][Full Text] [Related]
11. [18F]fluorodeoxyglucose positron emission tomography in the management of lymphomas.
Kostakoglu L
Clin Lymphoma Myeloma; 2008 Oct; 8(5):273-6. PubMed ID: 18854280
[No Abstract] [Full Text] [Related]
12. Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: a single center experience.
Edeline V; Bonardel G; Brisse H; Foehrenbach H; Pacquement H; Maszelin P; Gaillard JF; Michon J; Neuenschwander S
Leuk Lymphoma; 2007 Apr; 48(4):823-6. PubMed ID: 17454646
[No Abstract] [Full Text] [Related]
13. High-risk interim PET negative patients in Hodgkin's lymphoma.
Meignan M
Lancet Haematol; 2016 Oct; 3(10):e449-e450. PubMed ID: 27692302
[No Abstract] [Full Text] [Related]
14. FDG PET/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease.
Paes FM; Kalkanis DG; Sideras PA; Serafini AN
Radiographics; 2010 Jan; 30(1):269-91. PubMed ID: 20083598
[TBL] [Abstract][Full Text] [Related]
15. Surveillance imaging in pediatric lymphoma.
Voss SD; Cairo MS
Pediatr Radiol; 2019 Oct; 49(11):1565-1573. PubMed ID: 31620855
[TBL] [Abstract][Full Text] [Related]
16. Advanced Hodgkin's lymphoma: End-of-treatment FDG-PET should be maintained.
Hindié E; Mesguich C; Bouabdallah K; Milpied N
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(8):1254-1257. PubMed ID: 28466283
[No Abstract] [Full Text] [Related]
17. Staging and evaluation of the patient with lymphoma.
Cheson BD
Hematol Oncol Clin North Am; 2008 Oct; 22(5):825-37, vii-viii. PubMed ID: 18954739
[TBL] [Abstract][Full Text] [Related]
18. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
Chiusolo P; Sica S; Leone G
Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
[TBL] [Abstract][Full Text] [Related]
19. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
[TBL] [Abstract][Full Text] [Related]
20. Value of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan versus diagnostic contrast computed tomography in initial staging of pediatric patients with lymphoma.
Cheng G; Servaes S; Zhuang H
Leuk Lymphoma; 2013 Apr; 54(4):737-42. PubMed ID: 22957898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]